Average of confirmed sales; the main valuation baseline.
Lowest active listing; an asking price, not a completed sale.
Reference-price movement; low volume can make it unstable.
More sales reduce the impact of individual transactions.
Sales answer “what is it worth”; listings answer “what does an available copy cost”.
| DATE | SOURCE | Price | Change |
|---|---|---|---|
| 2026-10-06 | List | €3.70 | +5.7% |
| 2026-10-06 | Sold | €3.30 | -2.1% |
| 2026-10-05 | Sold | €3.37 | — |
| 2026-10-04 | Sold | €3.37 | — |
| 2026-10-03 | Sold | €3.37 | — |
| 2026-10-02 | Sold | €3.37 | — |
| 2026-10-01 | Sold | €3.37 | — |
| 2026-09-30 | Sold | €3.37 | — |
| 2026-09-29 | Sold | €3.37 | — |
| 2026-09-28 | Sold | €3.37 | — |
| 2026-09-27 | Sold | €3.37 | — |
| 2026-09-26 | Sold | €3.37 | — |
| 2026-09-25 | Sold | €3.37 | — |
| 2026-09-24 | Sold | €3.37 | +6.0% |
Facing a New Trial / #007
France: lowest · Germany: below average · EU average €4.70Choose a region above to inspect its prices and history.
DETAILED PRICES · Price History
| Condition/Grade | Price | LOW | HIGH | 7D CHG | Volume | Spark |
|---|---|---|---|---|---|---|
AggregatedRAW | €3.30 | €1.99 | €4.95 | -2.1% | >5 | |
NMRAW | €3.30 | €1.99 | €4.95 | -2.1% | >5 |
Explore Tapu Bulu GX (sm2+ 007) Facing a New Trial JP #007, Normal from Facing a New Trial, with 421 price records for the EU market. Prices above are labeled by source, currency and condition. Asking prices and recorded sales are different measures, not interchangeable valuations.